About AcuityMD

Developing and commercializing medical devices requires a unique approach to relationship building that spreadsheets and traditional CRMs can’t address.

AcuityMD is the MedTech Intelligence Platform.

More than 300 MedTech companies, including six of the top 10, use AcuityMD to identify target markets, uncover top opportunities, and grow revenue. From pre-commercial startups to global enterprises, our customers rely on AcuityMD to deliver the insights they need to understand where and how to sell, which accelerates the adoption of life-changing medical technology.

We built AcuityMD to help medical device companies focus their commercial efforts and increase revenue throughout the product lifecycle.

Our platform tackles the hard task of connecting external market and product information with your internal sales data so you can grow your accounts with unparalleled visibility into the market.

The AcuityMD platform

AcuityMD’s modules work together to power the MedTech commercial flywheel, connecting the end-to-end commercial process so companies can define and prioritize growth, measure and execute against their opportunities, and learn from the outcomes to ultimately build a stronger strategy.

Pipeline

Track and manage opportunities

Targeting

Find, qualify and act on high-value opportunities

Territories

Assign, manage, and compare territories

Markets

Size and segment markets

Care Journeys

Identify the right patients and win more business

Contracts

Accelerate sales and maximize contract performance

Who we are: Leadership team

With customers ranging from pre-commercial to enterprise, AcuityMD is committed to providing medtech companies unparalleled visibility to accelerate patient access to medical technology.‍

AcuityMD is an AI platform for MedTech trusted by nearly 500 MedTech companies – including eight of the top 10. Commercial leaders use AcuityMD to identify target markets, surface top opportunities, and grow their business. By combining real-world healthcare data with AI-powered insights, AcuityMD enables companies from pre-commercial to enterprise to understand where and how to sell faster to accelerate the adoption of medical technology.

AcuityMD was named to Forbes’ 2025 “Next Billion-Dollar Startups” list – an elite group of 25 venture-backed U.S. companies identified as most likely to reach a $1 billion valuation.